01.01.10
Location: Upper Tiberias, Israel
Sales: $104 million
Description:
Key Personnel
Rob Stollar, vice president, global sales and marketing; Ron Broshi, vice president of new product development; John Rank, director of sales and marketing—The Americas; Avi Bash, director of sales and marketing, Europe, Russia, Israel, Africa
Plants
Tiberias, Israel, Shamir, Israel, Roxboro, NC
Processes
Hydroentangled spunlaced
Major Markets
Wipes, hygiene, medical, industrial
Sales received a nice boost in 2009 for Israeli spunlace producer Spuntech Industries. The company, which was profiled last year for the first time in Nonwovens Industry’s top companies report, reported sales increased about 15% from $90 million to $104 million on growth in specialty engineered and value-added spunlace fabrics as well as growth in the company’s global capacity.
This growth is a continuation of a trend achieved yearly since the company opened its U.S. plant in 2006. In addition to a one-line plant in Roxboro, NC, Spuntech operates three lines—two in Galilee and one in Shamir—in Israel. It was founded in 1996 and is owned by Nissan Medical.
“Spuntech operates three state-of-the-art production facilities with a total of four production lines using sophisticated equipment with proprietary capabilities,” said John Rank, director of sales and marketing. “The company’s highly skilled engineers and technological staff, supported by a professional team of marketing, logistics, quality control and management personnel, have the ability to mass produce a variety of unique added-value products in accordance with stringent quality control guidelines, while meticulously adhering to delivery dates.”
Currently, Spuntech’s sales are split between North America, Europe and Asia where it serves wet and dry wipes, medical, technical and engineered fabrics markets. Describing spunlaced nonwovens as the fabric of choice for most of its customers, Mr. Rank reported that demand remained strong for high quality spunlaced nonwovens throughout 2009. “The market activity has been better than the global economy,” he said. “Threat of swine flu contributed to the overall market demand.”
Sales: $104 million
Description:
Key Personnel
Rob Stollar, vice president, global sales and marketing; Ron Broshi, vice president of new product development; John Rank, director of sales and marketing—The Americas; Avi Bash, director of sales and marketing, Europe, Russia, Israel, Africa
Plants
Tiberias, Israel, Shamir, Israel, Roxboro, NC
Processes
Hydroentangled spunlaced
Major Markets
Wipes, hygiene, medical, industrial
Sales received a nice boost in 2009 for Israeli spunlace producer Spuntech Industries. The company, which was profiled last year for the first time in Nonwovens Industry’s top companies report, reported sales increased about 15% from $90 million to $104 million on growth in specialty engineered and value-added spunlace fabrics as well as growth in the company’s global capacity.
This growth is a continuation of a trend achieved yearly since the company opened its U.S. plant in 2006. In addition to a one-line plant in Roxboro, NC, Spuntech operates three lines—two in Galilee and one in Shamir—in Israel. It was founded in 1996 and is owned by Nissan Medical.
“Spuntech operates three state-of-the-art production facilities with a total of four production lines using sophisticated equipment with proprietary capabilities,” said John Rank, director of sales and marketing. “The company’s highly skilled engineers and technological staff, supported by a professional team of marketing, logistics, quality control and management personnel, have the ability to mass produce a variety of unique added-value products in accordance with stringent quality control guidelines, while meticulously adhering to delivery dates.”
Currently, Spuntech’s sales are split between North America, Europe and Asia where it serves wet and dry wipes, medical, technical and engineered fabrics markets. Describing spunlaced nonwovens as the fabric of choice for most of its customers, Mr. Rank reported that demand remained strong for high quality spunlaced nonwovens throughout 2009. “The market activity has been better than the global economy,” he said. “Threat of swine flu contributed to the overall market demand.”